The sales volume of calcium channel blocker in Hangzhou has accounted for 53.04%, ACEI accounted for about 16.36% and angiotensin n acceptor antagonistic drug accounted for about 19.08% of the total consumption.

• 杭州地区的钙通道拮抗剂的用药金额约占抗高血压药总金额的53.；04%25；血管紧张素转换酶抑制药约占16